FFL
LGND icon

Future Fund LLC’s Ligand Pharmaceuticals LGND Stock Holding History

Future Fund LLC’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.76M Buy
13,840
+4,560
+49% +$902K 0.97% 41
2025
Q4 		$1.75M Buy
+9,280
New +$1.78M 0.56% 66

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Future Fund LLC's LGND Position: Q1 2026 in Review

Future Fund LLC increased its Ligand Pharmaceuticals (LGND) stake by 49% in Q1 2026, buying an estimated $902K and bringing the position to 13,840 shares worth $2.76M. The position accounts for 0.97% of the portfolio, ranked #41.

Future Fund LLC first reported a position in LGND in Q4 2025 and has held it in 2 quarters since. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Future Fund LLC held 13,840 shares of Ligand Pharmaceuticals worth $2.76M as of Q1 2026.
  • Future Fund LLC bought 4,560 Ligand Pharmaceuticals shares in Q1 2026, an estimated $902K.
  • Ligand Pharmaceuticals made up 0.97% of Future Fund LLC's portfolio in Q1 2026, its #41 holding.
  • Future Fund LLC first reported a position in Ligand Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Future Fund LLC's 13F filing for Q1 2026, filed 6 May 2026.